Alberto Cambrosio
#120,452
Most Influential Person Now
Sociologist
Alberto Cambrosio's AcademicInfluence.com Rankings
Download Badge
Sociology
Alberto Cambrosio's Degrees
- PhD Sociology Université de Montréal
- Masters Sociology Université de Montréal
- Bachelors Sociology Université de Montréal
Similar Degrees You Can Earn
Why Is Alberto Cambrosio Influential?
(Suggest an Edit or Addition)According to Wikipedia, Alberto Cambrosio is a sociologist of biomedicine at McGill University. He earned his PhD in History and Sociology of Science from the Université de Montréal. He holds a bachelor's degree in Biology from the University of Basel, Switzerland, and a master's degree in Environmental Science from the Université de Sherbrooke, Canada.
Alberto Cambrosio's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Biomedical Platforms: Realigning the Normal and the Pathological in Late-Twentieth-Century Medicine (2003) (327)
- Regulatory objectivity and the generation and management of evidence in medicine. (2006) (210)
- The emergence of clinical practice guidelines. (2007) (194)
- Historical scientometrics? Mapping over 70 years of biological safety research with coword analysis (1993) (137)
- Cancer on Trial: Oncology as a New Style of Practice (2011) (128)
- Mapping the emergence and development of translational cancer research. (2006) (123)
- Visual cultures of science : rethinking representational practices in knowledge building and science communication (2005) (111)
- “Going Monoclonal”: Art, Science, and Magic in the Day-to-Day Use of Hybridoma Technology (1988) (107)
- Living and Working with the New Medical Technologies: Intersections of Inquiry (2000) (96)
- Mapping Collaborative Work and Innovation in Biomedicine (2004) (87)
- Exquisite Specificity: The Monoclonal Antibody Revolution (1995) (78)
- Biomedical Conventions and Regulatory Objectivity (2009) (61)
- Cancer Clinical Trials: The Emergence and Development of a New Style of Practice (2007) (59)
- Ehrlich's "Beautiful Pictures" and the Controversial Beginnings of Immunological Imagery (1993) (58)
- On being “actionable”: clinical sequencing and the emerging contours of a regime of genomic medicine in oncology (2013) (55)
- Representing Biotechnology: An Ethnography of Quebec Science Policy (1990) (54)
- Regulating diagnosis in post-genomic medicine: re-aligning clinical judgment? (2011) (54)
- Cancer clinical trials in the era of genomic signatures: Biomedical innovation, clinical utility, and regulatory-scientific hybrids (2011) (50)
- Detection and characterization of translational research in cancer and cardiovascular medicine (2011) (49)
- A New Clinical Collective for French Cancer Genetics (2006) (48)
- Making a New Technology Work: The Standardization and Regulation of Microarrays (2007) (45)
- Scientific Practice in the Courtroom: The Construction of Sociotechnical Identities in a Biotechnology Patent Dispute (1990) (43)
- Biomedical Platforms (2000) (43)
- The Disciplinary Stake: The Case of Chronobiology (1983) (42)
- Controversies as governing processes in technology assessment (1991) (36)
- Extending experimentation: oncology’s fading boundary between research and care (2018) (36)
- The Invisible Topography of Power: Electromagnetic Fields, Bodies and the Environment (1997) (36)
- Testing devices or experimental systems? Cancer clinical trials take the genomic turn. (2014) (33)
- From Screening to Clinical Research: The Cure of Leukemia and the Early Development of the Cooperative Oncology Groups, 1955-1966 (2002) (33)
- Patents and Free Scientific Information in Biotechnology: Making Monoclonal Antibodies Proprietary (1990) (33)
- Pragmatic evidence and textual arrangements: a case study of French clinical cancer guidelines. (2010) (32)
- Biomedical innovation at the laboratory, clinical and commercial interface: A new method for mapping research projects, publications and patents in the field of microarrays (2008) (31)
- A Matter of FACS: Constituting Novel Entities in Immunology (1992) (27)
- Expertise as a Network: A Case Study of the Controversies over the Environmental Release of Genetically Engineered Organisms (1992) (27)
- Too many numbers: Microarrays in clinical cancer research. (2012) (27)
- Between fact and technique: The beginnings of hybridoma technology (1992) (26)
- The New Genetics and Cancer: The Contributions of Clinical Medicine in the Era of Biomedicine (2001) (25)
- Does Biomedicine Entail the Successful Reduction of Pathology to Biology? (2004) (25)
- Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and “Disruptive” Technologies (2017) (24)
- Singular selves : historical issues and contemporary debates in immunology (2001) (22)
- Arguing with Images: Pauling's Theory of Antibody Formation (2005) (20)
- Of lymphocytes and pixels: The techno-visual production of cell populations (2000) (20)
- Genomic platforms and hybrid formations (2009) (19)
- 11. The Tools of the Discipline: Standards, Models, and Measures in the Affinity/Avidity Controversy in Immunology (1992) (17)
- Genomic expertise in action: molecular tumour boards and decision-making in precision oncology. (2019) (17)
- "Triple negative breast cancer": Translational research and the (re)assembling of diseases in post-genomic medicine. (2016) (17)
- 1. Medical pedigrees and the visual production of family disease in Canadian and Japanese genetic counselling practice (2008) (17)
- Interlaboratory Life: Regulating Flow Cytometry (1998) (16)
- The commercial application of a scientific discovery: The case of the hybridoma technique (1988) (16)
- Aramis, ou l'Amour des Techniques.@@@Nous n'Avons Jamais ete Modernes: Essai d'Anthropologie Symetrique. (1993) (15)
- Régimes thérapeutiques et dispositifs de preuve en oncologie : l'organisation des essais cliniques, des groupes coopérateurs aux consortiums de recherche (2014) (15)
- “Ours is an engineering approach”: Flow cytometry and the constitution of human T-cell subsets (1994) (14)
- Living and Working with the New Medical Technologies: “Real compared to what?”: Diagnosing leukemias and lymphomas (2000) (14)
- Signs, markers, profiles, and signatures: clinical haematology meets the new genetics (1980–2000) (2004) (13)
- Therapy’s Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy (2013) (13)
- Les risques associés au largage dans l’environnement d’organismes génétiquement modifiés : analyse d’une controverse (1993) (13)
- The Automated Laboratory (1999) (13)
- ‘Overcoming the Bottleneck’: Knowledge Architectures for Genomic Data Interpretation in Oncology (2020) (12)
- Informing materials: drugs as tools for exploring cancer mechanisms and pathways (2017) (11)
- Mapping Global Health: A network analysis of a heterogeneous publication domain (2017) (11)
- Beyond "bad news": the diagnosis, prognosis and classification of lymphomas and lymphoma patients in the age of biomedicine (1945-1995). (2003) (11)
- Big Data and the Collective Turn in Biomedicine. How Should We Analyze Post-genomic Practices? (2014) (10)
- Oncology research in late twentieth century and turn of the century Portugal: a scientometric approach to its institutional and semantic dimensions (2017) (10)
- Qu’est-ce que la biomédecine ? Repères socio-historiques (2003) (9)
- 21st-century oncology: a tangled web (2013) (9)
- Who's minding the data? Data Monitoring Committees in clinical cancer trials. (2009) (9)
- Comparative Effectiveness Research in Health Technology Assessment (2015) (6)
- Beyond nosology? Molecular tumor boards, singularization, and the conflation of diagnosis and therapy (2020) (6)
- Phages, antibodies and de-monstration. (2008) (6)
- Les réseaux de l’expression génique (2012) (6)
- Genomic platforms and clinical research (2018) (6)
- Clinical trials in the age of personalized medicine (2011) (6)
- Rationalisation et médecine des preuves en oncologie : quelques remarques à propos de la régulation des pratiques biomédicales (2005) (5)
- Technique, outil, invention : les transformations d'une biotechnologie (1996) (5)
- Introduction: Immunology as a historical object (1994) (5)
- Living and Working with the New Medical Technologies: Introduction (2000) (5)
- Biomedical Sciences and Technology: History and Sociology (2001) (5)
- La politique scientifique comme représentation construite en contexte bureaucratique: le cas de À l'heure des biotechnologies (1991) (5)
- Multi-polar scripts: Techno-regulatory environments and the rise of precision oncology diagnostic tests. (2019) (5)
- Analyzing Science Policy-Making: Political Ontology or Ethnography?: A Reply to Kleinman (1991) (5)
- From BRCA to BRCAness: tales of translational research (2014) (5)
- New medical technologies and clinical practice: a survey of lymphocyte subset monitoring. (1994) (4)
- Plurality of Worlds, Plurality of Risks (1995) (4)
- Beyond networks: Aligning qualitative and computational science studies (2020) (4)
- Analysis of Heterogenous Networks: The ReseauLu Project (2010) (4)
- What’s in a Pill? On the Informational Enrichment of Anti-Cancer Drugs (2013) (4)
- Helpers and Suppressors: On Fictional Characters in Immunology (1997) (3)
- Organizing precision oncology: introduction to the special issue (2021) (3)
- Quand la psychologie fait son entrée à l'usine: sélection et contrôle des ouvriers aux Etats-Unis pendant les années 1910 (1980) (3)
- Argumentation, représentation, intervention : les rôles de l'imagerie dans les discours scientifiques (2000) (3)
- La fabrique d'une nouvelle science. La biologie moléculaire à l’âge atomique (1945–1964) (2009) (3)
- La médecine de précision en oncologie : challenges, enjeux et nouveaux paradigmes (2019) (3)
- Le Québec face aux biotechnologies (1985) (3)
- Cancer Research and Protocol Patients: From Clinical Material to Committee Advisors (2012) (2)
- Disaligning macro, meso and micro due process: a case study of office automation in Quebec colleges (1988) (2)
- Standardization Before Biomedicine: On Early Forms of Regulatory Objectivity (2010) (2)
- Medical Genetics at McGill: The History of a Pioneering Research Group. (2013) (2)
- Analyse communicationnelle et épistémologie des sciences sociales (2004) (2)
- Studying a Biotechnology Research Centre: A Note on Local Socio-political Issues (1985) (2)
- Domain-topic models with chained dimensions: modeling the evolution of a major oncology conference (1995-2017) (2019) (1)
- [The emergence and development of gene expression profiling: a key component of the 3B (bench, bedside, bytes) in translational research]. (2012) (1)
- Book Reviews/Comptes Rendus: La médecine expérimentale au tribunal. Implications éthiques de quelques procès médicaux au XXe siècle européen par Christian Bonah, Étienne Lepicard et Volker Roelcke, éds. (2005) (1)
- Risk on trial: The interaction of innovation and risk in cancer clinical trials (2006) (1)
- Molecularizing Biology and Medicine: New Practices and Alliances, 1910s-1970s. Soraya de Chadarevian , Harmke Kamminga (1999) (1)
- Decentering Life (2009) (1)
- Objectivité régulatoire et systèmes de preuves en médecine : le cas de la cancérologie (2007) (1)
- Les enjeux du progrès (1983) (1)
- Regulatory objectivity and tests systems in medicine: The case of cancerology (2006) (1)
- Making Collaboration Networks Visible (2005) (1)
- Steven Epstein .Inclusion: The Politics of Difference in Medical Research. xi + 416 pp., index. Chicago: University of Chicago Press, 2007. $29 (cloth). (2008) (0)
- Oncopolitics? Reshaping Collaborative Research (2011) (0)
- The Case of Chronobiology (2016) (0)
- the Successful Reduction of Pathology to Biology (2004) (0)
- A Relational Space of Substances and Regimens (2011) (0)
- first interlude Clinical Trial Statistics (2011) (0)
- BRCAness: Redefining BRCA genes in the era of postgenomic medicine (2012) (0)
- Looking Back and Looking Forward (2011) (0)
- Criticism and the Redefinition of Clinical Cancer Trials as an Autonomous Form of Research (2011) (0)
- Constituting Novel Entities in Immunology (2016) (0)
- Statisticians, Data Centers, and the Organization of Large-Scale Clinical Trials (2011) (0)
- second interlude Molecular Biology and Oncogenes (2011) (0)
- Reassembling The Cancer Clinic: Genomics, ‘Actionability' and Emerging Diagnostic Configurations (2014) (0)
- Targeted Therapy and Clinical Cancer Research (2011) (0)
- A Web of Trials (2011) (0)
- Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and “Disruptive” Technologies (2017) (0)
- Adriana Petryna.When Experiments Travel: Clinical Trials and the Global Search for Human Subjects. xii + 258 pp., bibl., index. Princeton, N.J./Oxford: Princeton University Press, 2009. $24.95 (paper). (2010) (0)
- Statisticians, Statistics, and Early Cooperative Clinical Trials (2011) (0)
- Book Review:Correcting the Blueprint of Life: An Historical Account of the Discovery of DNA Repair Mechanisms Errol C. Friedberg (1999) (0)
- Introduction: Historiographic Issues (1997) (0)
- Correction to: Informing materials: drugs as tools for exploring cancer mechanisms and pathways (2018) (0)
- The Collective Turn (2011) (0)
- Organizing precision medicine: A case study of Memorial Sloan Kettering Cancer Center's engagement in/with genomics. (2023) (0)
- From “Nonentity” to Global Network (2011) (0)
- Domain‐topic models with chained dimensions: Charting an emergent domain of a major oncology conference (2021) (0)
- Mapping Global Health: A network analysis of a heterogeneous publication domain (2017) (0)
- [Precision medicine in oncology: Challenges, stakes and new paradigms]. (2019) (0)
- A Landmark Clinical Trial (2011) (0)
- Oncology research in late twentieth century and turn of the century Portugal: a scientometric approach to its institutional and semantic dimensions (2017) (0)
- Cancer Research and Protocol Patients (2012) (0)
- Informing materials: drugs as tools for exploring cancer mechanisms and pathways (2017) (0)
- prelude Before There Were Trials (2011) (0)
- Correction to: Informing materials: drugs as tools for exploring cancer mechanisms and pathways (2017) (0)
- Magic Bullets? The Gleevec Trials (2011) (0)
- [What is biomedicine? A socio-historical outline]. (2003) (0)
- Intertextualité et archi-iconicité : le cas des représentations scientifiques de la réaction antigène-anticorps. (2004) (0)
- L'émergence du chercheur scientifique: les syndicats italiens de la recherche après 1945 (1985) (0)
- [Not Available]. (1980) (0)
- Healthcare policy by other means: Cancer clinical research as "oncopolicy". (2021) (0)
- L'autre face de l'informatisation du travail (1990) (0)
This paper list is powered by the following services:
Other Resources About Alberto Cambrosio
What Schools Are Affiliated With Alberto Cambrosio?
Alberto Cambrosio is affiliated with the following schools:
